BVS 241220 10.00C (BVS241220C10000) Stock Options, News & Quotes

US OptionsDetailed Quotes

BVS241220C10000

Watchlist

2.00
+0.35+21.21%

15min DelayClose Nov 21 16:00 ET

2.00High2.00Low

Intraday

5D
Daily

News

Earnings Call: Bioventus Reports Robust Q3 Growth, Raises Full-year Guidance
InvestingNov 6 13:24 ET
Bioventus Is Maintained at Buy by Canaccord Genuity
Dow JonesNov 6 12:58 ET · Ratings
Bioventus Analyst Ratings
BenzingaNov 6 12:47 ET · Ratings
Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Announces Target Price $17
Moomoo NewsNov 6 09:33 ET · Ratings
CCORF Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $15
Moomoo NewsNov 6 08:37 ET · Ratings
J.P. Morgan Maintains Bioventus(BVS.US) With Sell Rating, Announces Target Price $12
Moomoo NewsNov 6 07:31 ET · Ratings

Comments

Jsmooth420365

Sep 4 05:27

$Bioventus (BVS.US)$ WTH you get 6 from?.. is that where you shorted at? 🤦‍♂️🤣

Jsmooth420365

Sep 2 00:27

$Bioventus (BVS.US)$ thinking about opening up a small swing over 10.30 🤔 lots of resistance to the left tho..

Stock Region

May 7 13:55

Healing Solutions Company Announces Earnings: Beats Analyst Consensus By 200%

The company’s quarterly sales reached $129.457 million, exceeding the analyst consensus estimate of $118.380 million by 9.36 percent.
Bioventus Inc. (Nasdaq: BVS), a company in the field of active healing solutions, has recently announced its financial outcomes for the quarter ending March 30, 2024, displaying remarkable performance and growth that has surpassed expectations on multiple fronts. The company's earnings pe...

Kanasai

May 7 06:50

$Bioventus (BVS.US)$ Target 6

TIPSY

Mar 8 09:53

$Bioventus (BVS.US)$ 7.5